NAL 0.00% 0.6¢ norwood abbey limited

1 minute silence for NAL, page-8

  1. 299 Posts.
    lightbulb Created with Sketch. 5
    I think hold - FDA should be out soon - has australian approval already. This is a buying opportunity - as you know once FDA out - huge impact on price- market for transdermal delivery devices is enormous - if you dont know already - drug companies spend millions on development of this sort of tech - i am sure a drug company will buy in if FDA positive. eg durogesic patch for pain, is about the only drug for pain via TD route and market share has excalated beyond forcasts. If device can be approved - the skies the limit as no competitor and a host of drugs can be delivered in this way by a simple patch after the laser has treated the skin with a painless zap.
 
watchlist Created with Sketch. Add NAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.